Volume 28, Number 3—March 2022
Research
Overseas Treatment of Latent Tuberculosis Infection in US–Bound Immigrants
Table 2
Reason† | No. (%) respondents |
---|---|
Total | 2,873 (100) |
Too busy or too much stress currently | 881 (31) |
Study or IGRA not required for medical examination | 723 (25) |
Did not believe infected | 641 (22) |
Family advised against enrollment | 407 (14) |
Worried about blood draw | 178 (6) |
Worried that participation could delay immigration process | 37 (1) |
Believed BCG vaccination would protect them from TB | 27 (1) |
Worried about enrolling in research | 11 (<1) |
Worried that IGRA results may affect immigration status | 7 (<1) |
Concerned about taking medication | 6 (<1) |
Worried about stigma | 5 (<1) |
Inconvenient to return to CRH VMD | 5 (<1) |
Did not understand study | 1 (<1) |
Undecided | 1 (<1) |
*BCG, Bacille Calmette-Guérin; CRH VMD, Cho Ray Hospital Visa Medical Department; IGRA, interferon-γ release assay; TB, tuberculosis. †A total of 2,940 reasons were given (>1 reason could be provided by respondents).
Page created: December 13, 2021
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.